Hao Zhu - Concepedia

Author

Hao Zhu

United States Food and Drug Administration ORCID

Also Known As

Ait-Oudhia, Sihem, Barrett, Jeffrey S., H J Zhu, H. Zhu, Hao Zhu, James L. Weaver, Wang, Jijun, Z J Hao, Zhu H, Zhu, Hao

Publications

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Center for Drug Evaluation and Research Takeda (United States)University of Maryland, Baltimore Center for Devices and Radiological Health

About

Hao Zhu is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	528
2	Health Sciences	3	3	48
3	Engineering	1	1	10
4	Public Health	1	1	10
5	Anesthesia	1	1	12

Hao Zhu

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Model‐Informed Drug Development: Current US Regulatory Practice and Future Considerations Yaning Wang, Hao Zhu, Rajanikanth Madabushi, Clinical Pharmacology & Therapeutics	2019	202
Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation Colleen Kuemmel, Yuching Yang, Xinyuan Zhang, CPT Pharmacometrics & Systems Pharmacology	2019	151
Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary Katherine A. Thornton, Geoffrey Kim, V. Ellen Maher, Clinical Cancer Research Caprelsa TabletsU.s. FoodMedicineThyroid DiseasePharmacology	2012	147
Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions Joo Yeon Lee, Christine Garnett, Jogarao Gobburu, Clinical Pharmacokinetics Drug SafetyLabelling DecisionsNew Drug ApprovalPharmacometricsPharmacoepidemiology	2011	146
Connecting Hydroxychloroquine In Vitro Antiviral Activity to In Vivo Concentration for Prediction of Antiviral Effect: A Critical Step in Treating Patients With Coronavirus Disease 2019 Jianghong Fan, Xinyuan Zhang, Jiang Liu, Clinical Infectious Diseases PharmacotherapyVitro 50Antiviral DrugCovid-19Drug Resistance	2020	76
Landscape Analysis of the Application of Artificial Intelligence and Machine Learning in Regulatory Submissions for Drug Development From 2016 to 2021 Qi Liu, Ruihao Huang, Julie Hsieh, Clinical Pharmacology & Therapeutics	2022	76
Long short-term memory recurrent neural network for pharmacokinetic-pharmacodynamic modeling Xiangyu Liu, Chao Liu, Ruihao Huang, International Journal of Clinical Pharmacology and Therapeutics	2020	61
Current Status and Future Directions: The Application of Artificial Intelligence/Machine Learning for Precision Medicine Kunal Naik, Rahul K. Goyal, Luca Foschini, Clinical Pharmacology & Therapeutics	2023	53
Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug Administration Jane P. F. Bai, Justin Earp, Jeffry Florian, CPT Pharmacometrics & Systems Pharmacology Quantitative PharmacologySystem PharmacologyUs FoodSystems PharmacologyLandscape Analysis	2021	50
Covariate modeling in pharmacometrics: General points for consideration Kinjal Sanghavi, Jakob Ribbing, James A. Rogers, CPT Pharmacometrics & Systems Pharmacology	2024	36

Page 1